(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PYZCHIVA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

PYZCHIVA

ST13

US500000079366850

Class

5

Filing

79366850

Registration

7232809

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

04/02/2024

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

02/27/2023

Registration date

12/05/2023

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/05/2023

Last transaction

12/05/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

KR

Examiner

BARRETT, LEAH N

Law office

L60

Current location

TMEG LAW OFFICE 106

Holders and representatives

Holders

SAMSUNG BIOEPIS CO., LTD.

Representatives

Charles T. J. Weigell Fross Zelnick Lehrman & Zissu, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of hematologicalautoimmuneinflammatoryrespiratorytransplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the treatment of ulcerative colitis; antidiabetic preparations; human vaccine preparations; pharmaceutical preparationspharmaceutical preparationsbiological formulationsbiological preparationsantibody formulations and protein formulations for immunoregulation and for treatment of immunologic disordersautoimmune diseasesinflammatory diseasesarthritiscancertumorcentral nervous system disorders and metabolic diseases; anti-inflammatory preparations; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for the treatment of diseases of the metabolic system; medicated pharmaceutical preparations for skin treatment; pharmaceutical preparations for psoriasis treatment; pharmaceutical preparations for the treatment of psoriatic arthritis; pharmaceutical preparations for the treatment of Crohn's disease

Publications

History of USPTO decisions and trademark events.

26 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/02/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/07/2024

FIMP

FINAL DISPOSITION PROCESSED

03/07/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/05/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/05/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

12/05/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/19/2023

PUBO

PUBLISHED FOR OPPOSITION

09/19/2023

GPNX

NOTIFICATION PROCESSED BY IB

09/18/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/30/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

08/30/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/30/2023

RFNT

REFUSAL PROCESSED BY IB

08/22/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/17/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/16/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/15/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/15/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/03/2023

RFRR

REFUSAL PROCESSED BY MPU

08/03/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/27/2023

CNRT

NON-FINAL ACTION WRITTEN

06/26/2023

DOCK

ASSIGNED TO EXAMINER

06/22/2023

MAFR

APPLICATION FILING RECEIPT MAILED

04/18/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/12/2023

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

04/11/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

04/06/2023

Continuous trademark protection

Get notified about every new filing that threatens PYZCHIVA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.